Sarah Michelle Gellar shares her family's experience with myopia

Article

Actress, producer, and entrepreneur Sarah Michelle Gellar chats with Optometry Times® editors Brooke Beery and Gretchyn M. Bailey, NCLC, FAAO, about myopia management. Gellar is spokesperson for CooperVision's Brilliant Futures myopia management program. She discusses screen use and her children, her son's foray into myopia management, and the importance of ODs communicating with patients the options around myopic correction.

Related: Sarah Michelle Gellar looks to slay myopia in MiSight campaign

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Erin Tomiyama, OD, PhD, FAAO, discusses fitting lenses, young adults with binocular vision issues, and emerging presbyopia in patients.
Dr. Mark Bullimore investigates myopia in an omnibus model at AAOpt 2024
© 2024 MJH Life Sciences

All rights reserved.